# Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia

> **NCT04557137** · — · UNKNOWN · sponsor: **University of Aarhus** · enrollment: 100 (estimated)

## Conditions studied

- Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)

## Interventions

- **DRUG:** Somatostatin analog

## Key facts

- **NCT ID:** NCT04557137
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557137, "Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04557137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*